High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital [2]

International Journal of Antimicrobial Agents

Volumn 23, Issue 5, 2004, Pages 529-530

  Garnier, Fabien ^a,b   Ducancelle, Alexandra ^a   Boisset, Sandrine ^b   Pineiro, Armelle ^a   Bergeret, Michel ^a   Denis, François ^b   Raymond, Josette ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENETIC ANALYSIS; GENOTYPE; HOSPITAL INFECTION; HUMAN; INCIDENCE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DNA, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FRANCE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; TEICOPLANIN; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 2342640198     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.01.003     Document Type: Letter

References (13)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med 1991;(Suppl 3B):72S-5S.
2. Endtz H.P., Van den Braak N., Verbrugh H.A., Van Belkhum A. Vancomycin resistance: status quo and quo vadis. Eur J Clin Microbiol Infect Dis. 18:1999;683-690
3. Arthur M., Molinas C., Depardieu F., Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring Enterococcus glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol. 175:1993;117-127
4. Arthur M., Reynolds P.E., Courvalin P. Glycopeptide resistance in enterococci. Trends Microbiol. 4:1996;401-407
5. Fines M., Périchon B., Reynolds P.E., Sahm D.F., Courvalin P. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother. 43:1999;2161-2164
6. Depardieu F., Bonora M.G., Reynolds P.E., Courvalin P. The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Mol Microbiol. 50:2003;931-948
7. Périchon B., Reynolds P.E., Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother. 41:1997;2016-2018
8. Moellering R.C. Jr. The spectre of glycopeptide resistance: current trends and future considerations. Am J Med. 104:1998;3-6
9. Felmingham D., Brown D.F., Soussy C.J. the European glycopeptide resistance survey study group. European glycopeptide susceptibility survey of Gram-positive bacteria for 1995. Diag Microbiol Infect. Dis. 31:1998;563-571
10. Dutka-Malen S., Evers S., Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 33:1995;24-27
11. Patel R., Uhl J.R., Kohner P., Hopkins M.K., Cockerill F.R. III Multiplex PCR detection of vanA, vanB vanC-1, and vanC-2/3 genes in enterococci. J Clin Microbiol. 35:1997;703-707
12. Schouten M.A., Hoogkam-Korstanje J.A.A., Meis J.F.G., Voss A. the European VRE Study Group Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis. 19:2000;816-822
13. Manson J.M., Keis S., Smith J.M., Cook G.M. A clonage lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant enterococci isolated in New Zealand. Antimicrob Agents Chemother. 47:2003;204-210